Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference

Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference   NEW YORK – November 25, 2020 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other…